Peer-influenced content. Sources you trust. No registration required. This is HCN.
Addiction Professional
Originally published in JAMA Psychiatry, a broad-based study shows nearly 7% of OUD patients are adding buprenorphine to urine sample to fake treatment adherence. Buprenorphine spiking suggests to the physician that the treatment plan is not working—especially in patients continuing illicit drug use.
Psychiatry April 3rd 2023
Pharmacy Practice News
Anyone who handles controlled substances must review their policies and procedures for identifying suspect prescriptions and taking appropriate action when necessary. Safe controlled substance (CS) handling procedures must also be followed by manufacturers and distributors. Thankfully, pharmacies can use tactics to spot questionable prescriptions, evade DEA inspections, and—most importantly—protect the health of their customers. But what comes first? Understanding what a red-flag prescription is.
Clinical Pharmacology March 31st 2023
ACP Internist
The extensive training requirements and caps on patients treated have been removed. That means all prescriptions for buprenorphine now require only a standard DEA registration number.
Pain Medicine March 14th 2023
Excessive alcohol use has continued to climb since the beginning of the COVD pandemic, and is a causal factor in one of every five deaths in the 20-to-49-year age group in the US.
Psychiatry March 14th 2023
Oregon Health & Science University (OHSU) researchers were searching a genetic database for compounds that could suppress the expression of genes previously linked to heavy alcohol use. They put apremilast to the test in two animal models with a genetic risk of binge drinking, as well as in mice from other labs. In each case, apremilast reduced alcohol consumption by increasing activity in the nucleus accumbens, the brain region involved in controlling alcohol intake. Scripps Research Institute then assessed 51 patients over 11 days of treatment and discovered that trial participants’ alcohol consumption was reduced from an average of five drinks per day to two.
Neurology March 7th 2023
Psychiatrist.com
There is no readily available test for xylazine and narcotic antagonists are ineffective. Overdosage is characterized by sedation and unresponsiveness. When combined with fentanyl, overdose symptoms can include blue-to-grayish skin, slowed breathing and bradycardia.
Psychiatry March 7th 2023